VIRNAX

Serial Number 75597698
606

Registration Progress

Application Filed
Dec 1, 1998
Under Examination
Feb 1, 2000
Approved for Publication
Oct 8, 1999
Published for Opposition
Nov 9, 1999
Registered

Basic Information

Serial Number
75597698
Filing Date
December 1, 1998
Published for Opposition
November 9, 1999
Abandonment Date
February 2, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 2, 2003
Classes
005

Rights Holder

Sanofi

03
Address
174 Avenue de France
75013 Paris
FR

Ownership History

Sanofi

Original Applicant
03
75013 Paris FR

Sanofi

Owner at Publication
03
75013 Paris FR

Legal Representation

Attorney
LINDA L. BERKOWITZ
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Nov 07, 1999 9374 days overdue Medium Until Dec 07, 1999

Application History

23 events
Date Code Type Description
Sep 12, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Aug 22, 2002 EX5G S SOU EXTENSION 5 GRANTED
Jul 26, 2002 MAIL I PAPER RECEIVED
Jul 26, 2002 EXT5 S SOU EXTENSION 5 FILED
Jan 15, 2002 EX4G S SOU EXTENSION 4 GRANTED
Dec 20, 2001 EXT4 S SOU EXTENSION 4 FILED
Jul 24, 2001 EX3G S SOU EXTENSION 3 GRANTED
Jul 9, 2001 EXT3 S SOU EXTENSION 3 FILED
Jul 8, 2001 EX2G S SOU EXTENSION 2 GRANTED
Jun 29, 2001 REIN O REINSTATED
Jun 5, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jan 19, 2001 EXT2 S SOU EXTENSION 2 FILED
Sep 11, 2000 EX1G S SOU EXTENSION 1 GRANTED
Jul 12, 2000 EXT1 S SOU EXTENSION 1 FILED
Feb 1, 2000 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 8, 1999 DOCK D ASSIGNED TO EXAMINER
Nov 9, 1999 PUBO A PUBLISHED FOR OPPOSITION
Oct 8, 1999 NPUB O NOTICE OF PUBLICATION
Aug 4, 1999 DOCK D ASSIGNED TO EXAMINER
Aug 4, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 1999 DOCK D ASSIGNED TO EXAMINER
Jun 14, 1999 CNRT F NON-FINAL ACTION MAILED

Detailed Classifications

Class 005
Antiviral pharmaceutical preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005